Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IMA
STRONG SELLImageneBio, Inc. · Healthcare · United States · $63M · Avg Vol: $65K/d
11
StockRankGet insider-trade alerts
Q
29
V
33
M
26
P/E (TTM)
—
ROE
-86.2%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)-0.4%
SMA 50SMA 200
Close
$5.60
RSI (14)
39.3
52W High
$18.00
From 52W High
0.3%
SCORE BREAKDOWN
Quality
29
ROIC
-34.2%21.5
ROE
-86.2%10.5
GP/Assets
0.0%10.1
Op. Margin
0.0%41.3
FCF/Assets
-17.8%21.1
Piotroski
111.4
Int. Cover
—N/A
D/E Ratio
0.02x79.4
Current Ratio
18.39x94.4
Value
33
P/E (TTM)
—N/A
EV/EBITDA
1.0x25.0
P/FCF
—N/A
P/B
0.5x96.8
P/S
—0.3
Div Yield
—N/A
Momentum
26
52W High %
31%8.8
RS 6M
-30%31.4
SMA 50/200
0.90x40.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+17%32.5
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$63M
P/E (Forward)
-1.4x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IMA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IMA | ImageneBio, Inc.(you) | $63M | 11 | STRONG SELL |
| CING | Cingulate Inc. | $62M | 11 | STRONG SELL |
| KALA | KALA BIO, Inc. | $63M | 9 | STRONG SELL |
| HYFT | MindWalk Holdings Corp. | $64M | 8 | STRONG SELL |
| CNTX | Context Therapeutics Inc. | $56M | 10 | STRONG SELL |
| FLNA | Filana Therapeutics, Inc. | $58M | 13 | STRONG SELL |
| MNOV | MediciNova, Inc. | $65M | 14 | STRONG SELL |
| MAIA | MAIA Biotechnology, Inc. | $75M | 12 | STRONG SELL |
| GOSS | Gossamer Bio, Inc. | $66M | 8 | STRONG SELL |
| TIL | Instil Bio, Inc. | $50M | 11 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%